Gamma Medica-Idea (Northridge, CA) developer of digital molecular imaging devices for the research and clinical imaging markets, closed a $14M Series A financing. Participants include Psilos Group and Capital Resource Partners.

Foundation Radiology Group (Pittsburgh, PA) a diagnostic imaging professional services company offering on-site radiology and teleradiology solutions for hospital institutions and outpatient imaging centers, closed a $10M Series A financing. Participants include Chrysalis Ventures and Health Evolution Partners.

Nexstim (Finland) a commercial-stage developer of non-invasive brain imaging technologies focused on cortical mapping prior to surgery, closed a $7.9M Series C financing. Participants include Tekes, HealthCap, Life Sciences Partners, Sitra and Finnish Industry Investment Ltd.

Diagnosoft (Morrisville, NC) an early-stage device company focused on analyzing MRI images of the heart to measure and visualize cardiac muscle function, closed a $4M Series B financing. Participants include Technology Development Fund.

Rcadia Medical Imaging (Israel) developer of image processing based software products for blood vessel analysis closed a $3.3M Series B financing. Participants include BioVentures Investors and 20/20 HealthCare Partners.

Celleration (Eden Prairie, MN) commercial-stage medical device company focused on non-contact ultrasound device for wound care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

ViewRay (Gainesville, FL)  maker of  a MRI-guided radio-therapy delivery device, closed a $25M Series B financing. Participants include OrbiMed, Fidelity Biosciences, Aisling Capital, Kearny and Venture Partners.

Mauna Kea Technologies (France) a MIS in-vivo imaging platform has closed a $30M Series B financing. Participants include Psilos Group, Seventure and Creadev.

Point Biomedical (San Carlos, CA) a myocardial perfusion imaging platform has closed a $50M Series A recapitalization financing. Participants include Vedanta Capital, Amberbrook, Fininvest, INVESCO Private Capital, New Leaf Venture Partners, Saratoga Ventures, William Blair Capital Partners, De Novo Ventures, Institutional Venture Partners, Saints Capital, Sprout Group and CHL Medical Partners.

Caprotec Bioanalytics (Germany) maker of a mass-spec based compound capture platform for drug development and protein biomarker identification closed a $8.8M Series B financing. Participants include Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds and private investors.

ViOptix (Freemont, CA) developer of optical diffusion imaging and spectroscopy technology to enable non-invasive measurement of local tissue oxygen saturation closed a $12.2M Series D. Participants include Channel Medical Partners, Lincoln Funds International, Canadian Medical Discoveries Fund and Morningside Technology Ventures.

Confirma (Bellevue, WA) maker of MRI detection technology closed a $17.5M Series C. Participants include Telegraph Hill Partners, Fluke Venture Partners, Prism Ventureworks and Versant Ventures.

Sanarus Medical (Pleasanton, CA) a biopsy device company focused on diagnosis and treatment of breast tumors raised $15M in Series E funding. Participants included Easton Capital Partners, Alta Partners, Forward Ventures, Channel Medical Partners, Federated Kaufman Fund, Pequot Private Equity and U.S. Venture Partners.